Large-scale testing (Phase 3)UnknownNCT03746665What this trial is testingMaternal Immunization With MenAfriVac™Who this might be right forMeningitisMeningococcal London School of Hygiene and Tropical Medicine 200
Testing effectiveness (Phase 2)Study completedNCT00443157What this trial is testingMeningococcal B Vaccination in University StudentsWho this might be right forNeisseria Meningitidis Serogroup B Public Health England 50
Testing effectiveness (Phase 2)Study completedNCT00134719What this trial is testingHib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate VaccinesWho this might be right forNeisseria MeningitidisHaemophilus Influenzae Type b GlaxoSmithKline 1,104
Testing effectiveness (Phase 2)Study completedNCT00314041What this trial is testingStudy Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in InfantsWho this might be right forMeningitis, Meningococcal Wyeth is now a wholly owned subsidiary of Pfizer 240
Large-scale testing (Phase 3)Study completedNCT01339923What this trial is testingA Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 YearsWho this might be right forMeningococcal DiseaseMeningococcal Meningitis Novartis Vaccines 1,409
Large-scale testing (Phase 3)Study completedNCT01423084What this trial is testingSafety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 YearsWho this might be right forMeningococcal DiseaseMeningococcal Meningitis Novartis 344
Large-scale testing (Phase 3)Active Not RecruitingNCT06446752What this trial is testingBIYELA - Bexsero Immunisation in Young Women in AfricaWho this might be right forGonorrheaGonorrhea of PharynxGonorrhea of Anus+1 more University of Washington 1,100
Testing effectiveness (Phase 2)Study completedNCT06128733What this trial is testingStudy of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and AdolescentsWho this might be right forMeningococcal ImmunisationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 1,215
Testing effectiveness (Phase 2)Ended earlyNCT00772629What this trial is testingAntibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy AdultsWho this might be right forMeningitisMeningococcemia Sanofi Pasteur, a Sanofi Company 18
Large-scale testing (Phase 3)Study completedNCT04143061What this trial is testingImmunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South AfricaWho this might be right forMeningococcal ImmunizationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 1,328
Early research (Phase 1)Ended earlyNCT04825223What this trial is testingStudy of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and InfantsWho this might be right forMeningococcal ImmunisationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 576
Large-scale testing (Phase 3)Study completedNCT00955682What this trial is testingStudy to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612Who this might be right forInfections, Meningococcal GlaxoSmithKline 342
Large-scale testing (Phase 3)Study completedNCT01894919What this trial is testingAntibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28Who this might be right forMeningoccocal DiseaseMeningococcal Meningitis Novartis Vaccines 851
Large-scale testing (Phase 3)Study completedNCT00496015What this trial is testingProphylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850AWho this might be right forInfections, Streptococcal GlaxoSmithKline 750
Testing effectiveness (Phase 2)Study completedNCT00390143What this trial is testingStudy in Adolescents/Adults to Evaluate the Persistence up to 3.5 Yrs of GSK Biologicals Meningococcal Vaccine 134612Who this might be right forInfections, Meningococcal GlaxoSmithKline 46
Large-scale testing (Phase 3)Study completedNCT00474539What this trial is testingStudy Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy InfantsWho this might be right forVaccines, Pneumococcal Wyeth is now a wholly owned subsidiary of Pfizer 449
Not applicableStudy completedNCT03824093What this trial is testingHigh and Low Resource Interventions to Promote HPV VaccinesWho this might be right forHuman Papilloma VirusTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationMeningitis, Meningococcal+2 more Children's Mercy Hospital Kansas City 225
Testing effectiveness (Phase 2)Study completedNCT02946385What this trial is testingStudy to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in AdolescentsWho this might be right forInfections, Meningococcal GlaxoSmithKline 604
Large-scale testing (Phase 3)Study completedNCT00806195What this trial is testingStudy to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy InfantsWho this might be right forMeningitisMeningococcal Infection Novartis 7,744
Post-approval studies (Phase 4)Study completedNCT05929651What this trial is testingStudy of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in InfancyWho this might be right forMeningococcal ImmunisationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 71